Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus

Autor: Shanmugavel Geetha, Harinivaas, Teo, Yi Xiang, Ravichandran, Sharmitha, Perkit, Navya Reddy, Gogtay, Maya, Lal, Amos, Abraham, George M., Trivedi, Nitin
Zdroj: In Respiratory Medicine November-December 2024 234
Databáze: ScienceDirect
Externí odkaz: